ATE227775T1 - Impfstoff-vektoren von rekombinantem katzen- herpesvirus - Google Patents

Impfstoff-vektoren von rekombinantem katzen- herpesvirus

Info

Publication number
ATE227775T1
ATE227775T1 AT93917639T AT93917639T ATE227775T1 AT E227775 T1 ATE227775 T1 AT E227775T1 AT 93917639 T AT93917639 T AT 93917639T AT 93917639 T AT93917639 T AT 93917639T AT E227775 T1 ATE227775 T1 AT E227775T1
Authority
AT
Austria
Prior art keywords
fhv
herpes virus
vaccine vectors
recombinant feline
feline herpes
Prior art date
Application number
AT93917639T
Other languages
English (en)
Inventor
Paulus Jacobus An Sondermeijer
Martha Jacoba Willemse
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8210815&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE227775(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE227775T1 publication Critical patent/ATE227775T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compression Or Coding Systems Of Tv Signals (AREA)
  • Peptides Or Proteins (AREA)
AT93917639T 1992-07-30 1993-07-23 Impfstoff-vektoren von rekombinantem katzen- herpesvirus ATE227775T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92202365 1992-07-30
PCT/EP1993/001971 WO1994003621A1 (en) 1992-07-30 1993-07-23 Vector vaccines of recombinant feline herpesvirus

Publications (1)

Publication Number Publication Date
ATE227775T1 true ATE227775T1 (de) 2002-11-15

Family

ID=8210815

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93917639T ATE227775T1 (de) 1992-07-30 1993-07-23 Impfstoff-vektoren von rekombinantem katzen- herpesvirus

Country Status (10)

Country Link
US (1) US6521236B1 (de)
EP (1) EP0606452B1 (de)
JP (1) JP3529134B2 (de)
AT (1) ATE227775T1 (de)
AU (1) AU4702293A (de)
DE (1) DE69332480T2 (de)
DK (1) DK0606452T3 (de)
ES (1) ES2187508T3 (de)
PT (1) PT606452E (de)
WO (1) WO1994003621A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000172A1 (en) * 1993-06-24 1995-01-05 Michigan State University Recombinant deletion feline herpesvirus vaccine and method for the preparation thereof
DE69535125T2 (de) * 1994-04-29 2007-08-30 Pharmacia & Upjohn Co. Llc, Kalamazoo Impfstoff gegen felines immunodefizienz-virus
FR2741806B1 (fr) * 1995-11-30 1998-02-20 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
US6231863B1 (en) 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
BR9915970A (pt) * 1998-05-01 2001-12-04 Schering Plough Ltd Vìrus recombinante expressando dna exógenocodificando cd80 felino, ctla-4 felino ou cd86 felinoe usos do mesmo
US7279168B2 (en) 1998-05-01 2007-10-09 Texas A & M University System Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof
JP2002112770A (ja) 2000-10-05 2002-04-16 Kyoritsu Seiyaku Kk 新規組換えネコヘルペスウイルス１型およびこれを用いた多価ワクチン
WO2009051823A2 (en) * 2007-10-18 2009-04-23 Michigan State University Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0231209B1 (de) * 1985-07-29 1991-02-06 The Upjohn Company Virus-impfstoff
US5223424A (en) * 1985-09-06 1993-06-29 Prutech Research And Development Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
EP0256092B1 (de) * 1986-01-27 1998-04-08 Syntro Corporation Abgeschwächte herpesviren, herpesviren, die eine für aminosäuresequenzen kodierende fremd-dns enthalten, sowie impfstoffe, die diese enthalten
US5324664A (en) * 1988-08-08 1994-06-28 The Upjohn Company Herpes virus thymidien kinase-encoding DNA
ES2070997T3 (es) * 1989-12-04 1995-06-16 Akzo Nobel Nv Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
FR2666589B1 (fr) * 1990-09-07 1994-08-05 Rhone Merieux Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
WO1995000172A1 (en) 1993-06-24 1995-01-05 Michigan State University Recombinant deletion feline herpesvirus vaccine and method for the preparation thereof

Also Published As

Publication number Publication date
DE69332480D1 (de) 2002-12-19
WO1994003621A1 (en) 1994-02-17
JP3529134B2 (ja) 2004-05-24
DE69332480T2 (de) 2003-07-17
AU4702293A (en) 1994-03-03
DK0606452T3 (da) 2003-03-17
JPH06511392A (ja) 1994-12-22
ES2187508T3 (es) 2003-06-16
US6521236B1 (en) 2003-02-18
EP0606452A1 (de) 1994-07-20
PT606452E (pt) 2003-03-31
EP0606452B1 (de) 2002-11-13

Similar Documents

Publication Publication Date Title
CA2031164A1 (en) Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
CA2161962A1 (en) Adenovirus vectors for gene therapy
OA09777A (en) "Viral defective vaccine produced by transcomplementing cell line"
EP0596979A4 (en) Recombinant plant viral nucleic acids.
MX9700833A (es) Virus de herpes recombinante de pavo y usos del mismo.
EP0677114A4 (de) Rekombinanter schweinepocken-virus.
EP0275300A4 (de) Rekombinanter impfstoff.
DE69332393D1 (de) Rekombinanter Katzen-Herpesvirus-Impfstoff
ATE227775T1 (de) Impfstoff-vektoren von rekombinantem katzen- herpesvirus
NO922728L (no) Vaksine mot coccidiose
NZ508892A (en) Nucleic acid encoding a vaccine-induced mutant major surface antigen of a hepatitis B viral strain
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
SG43029A1 (en) Recombinant adenovirus vaccines
AU1624292A (en) Recombinant vaccine against marek's disease
SG52780A1 (en) Vaccine against mumps containing a jeryl-lynn virus strain
Willemse et al. Recombinant feline herpesvirus vaccine
MY118955A (en) Mutant human hepatitis b viral strain and uses thereof.
Keil Vector vaccines of bovine herpesvirus I
MX9709514A (es) Viruses de fowlpox recombinantes y usos de los mismos.
RU93005232A (ru) Вирусы, применение вирусов, вакцина, способ получения вируса

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0606452

Country of ref document: EP

REN Ceased due to non-payment of the annual fee